Zobrazeno 1 - 10
of 614
pro vyhledávání: '"Per Ljungman"'
Autor:
Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Yu Gao, Gunnar Söderdahl, Anders Österborg, C.I.Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Per Ljungman, Marcus Buggert, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
EBioMedicine, Vol 109, Iss , Pp 105385- (2024)
Summary: Background: Immunocompromised patients with primary and secondary immunodeficiencies have shown impaired responses to SARS-CoV-2 mRNA vaccines, necessitating recommendations for additional booster doses. However, longitudinal data reflecting
Externí odkaz:
https://doaj.org/article/e065b36ec6674ac794485395f839553b
Autor:
Kenny A Rodriguez-Wallberg, Jonas Bergh, Antonis Valachis, Per Frisk, Theodoros Foukakis, Per Ljungman, Sandra Eloranta, Hanna Pauline Nilsson, Johan Malmros, Christina Linder Stragliotto, Erika Isaksson Friman, Barbro Linderholm, Anne Andersson, Sara Harrysson, Lovisa Vennström, Helena Mörse
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Background Gonadotropin-releasing hormone agonists (GnRHa) cotreatment used to transiently suppress ovarian function during chemotherapy to prevent ovarian damage and preserve female fertility is used globally but efficacy is debated. Most clinical s
Externí odkaz:
https://doaj.org/article/ba5924fc50df467589005f382b3a4808
Autor:
Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C.I. Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Marcus Buggert, Per Ljungman, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
EBioMedicine, Vol 94, Iss , Pp 104700- (2023)
Summary: Background: Immunocompromised patients have varying responses to SARS-CoV-2 mRNA vaccination. However, there is limited information available from prospective clinical trial cohorts with respect to long-term immunogenicity-related responses
Externí odkaz:
https://doaj.org/article/2329229490de4fbd80902984341b218f
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/b50e1b698a2c4e8393a24923b721cbda
Autor:
Per Ljungman, Gloria Tridello, Jose Luis Piñana, Fabio Ciceri, Henrik Sengeloev, Alexander Kulagin, Stephan Mielke, Zeynep Arzu Yegin, Matthew Collin, Sigrun Einardottir, Sophie Ducastelle Lepretre, Johan Maertens, Antonio Campos, Elisabetta Metafuni, Herbert Pichler, Frantisek Folber, Carlos Solano, Emma Nicholson, Meltem Kurt Yüksel, Kristina Carlson, Beatriz Aguado, Caroline Besley, Jenny Byrne, Immaculada Heras, Fiona Dignan, Nicolaus Kröger, Christine Robin, Anjum Khan, Stig Lenhoff, Anna Grassi, Veronika Dobsinska, Nuno Miranda, Maria-Jose Jimenez, Ipek Yonal-Hindilerden, Keith Wilson, Dina Averbuch, Simone Cesaro, Alienor Xhaard, Nina Knelange, Jan Styczynski, Malgorzata Mikulska, Rafael de la Camara
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCOVID-19 has been associated with high morbidity and mortality in allogeneic hematopoietic stem cell transplant (allo-HCT) recipients.MethodsThis study reports on 986 patients reported to the EBMT registry during the first 29 months of th
Externí odkaz:
https://doaj.org/article/34d0341b3015429d8b862b7e7130e615
Autor:
Angelica Cuapio, Caroline Boulouis, Iva Filipovic, David Wullimann, Tobias Kammann, Tiphaine Parrot, Puran Chen, Mira Akber, Yu Gao, Quirin Hammer, Benedikt Strunz, André Pérez Potti, Olga Rivera Ballesteros, Joshua Lange, Jagadeeswara Rao Muvva, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C. I. Edvard Smith, Gordana Bogdanovic, Sandra Muschiol, Fredrika Hellgren, Karin Loré, Michal J. Sobkowiak, Giorgio Gabarrini, Katie Healy, Margaret Sällberg Chen, Evren Alici, Niklas K. Björkström, Marcus Buggert, Per Ljungman, Johan K. Sandberg, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-12 (2022)
Abstract Adaptive immune responses have been studied extensively in the course of mRNA vaccination against COVID-19. Considerably fewer studies have assessed the effects on innate immune cells. Here, we characterized NK cells in healthy individuals a
Externí odkaz:
https://doaj.org/article/385ad681ef5c4016a17b2e4b36257493
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
In allogeneic hematopoietic cell transplantation (allo-HSCT), both virus-specific T cells and leukemia-specific T cells need to be reconstituted to protect patients from virus infections and primary disease relapse. Cytomegalovirus (CMV) infection re
Externí odkaz:
https://doaj.org/article/796155f0ff6044b591c5edf8d0ed5a78
Autor:
Mahin Ghorbani, Khaled Al-Manei, Sabrina Naud, Katie Healy, Giorgio Gabarrini, Michal Jacek Sobkowiak, Puran Chen, Shilpa Ray, Mira Akber, Sandra Muschiol, Gordana Bogdanovic, Peter Bergman, Per Ljungman, Marcus Buggert, Hans-Gustaf Ljunggren, Elisa Pin, Piotr Nowak, Soo Aleman, Margaret Sällberg Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Coevolution of microbiome and immunity at mucosal sites is essential for our health. Whether the oral microbiome, the second largest community after the gut, contributes to the immunogenicity of COVID-19 vaccines is not known. We investigated the bas
Externí odkaz:
https://doaj.org/article/bf6a4b68d35e448185d17db4ef7dbf4b
Autor:
Sigrun Einarsdottir, Anna Martner, Malin Nicklasson, Hanna Grauers Wiktorin, Mohammad Arabpour, Andreas Törnell, Krista Vaht, Jesper Waldenström, Johan Ringlander, Tomas Bergström, Mats Brune, Kristoffer Hellstrand, Per Ljungman, Martin Lagging
Publikováno v:
Haematologica, Vol 107, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/ea5b9a1ee7804213a6df1bdd75b6b708
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
Autor:
Erik Boberg, Lena vonBahr, Gabriel Afram, Carina Lindström, Per Ljungman, Nina Heldring, Peter Petzelbauer, Karin Garming Legert, Nadir Kadri, Katarina Le Blanc
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 10, Pp 1190-1202 (2020)
Abstract Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on 11 patients with severe, refractory cGvHD treated with repeated infusions of
Externí odkaz:
https://doaj.org/article/16d0c6414fc74e21b153c67ffa2c49aa